We are live on ! Find out more
STLNW

Starling Oncology, Inc. Warrant
STLNW

16 hedge funds and large institutions have $807K invested in Starling Oncology, Inc. Warrant in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

98% more capital invested

Capital invested by funds: $407K → $807K (+$400K)

14% more funds holding

Funds holding: 14 → 16 (+2)

0.13% more ownership

Funds ownership: 5.96% → 6.09% (+0.13%)

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
2
Closed
2
Calls
$17K
Puts
–
Net Calls
+$17K
Net Calls Change
+$2K

Top Buyers

Rank Fund Capital Flow
1
Man Group
Man Group
United Kingdom
+$14K
2
Walleye Capital
Walleye Capital
New York
+$9.51K
3
LP
LMR Partners
United Kingdom
+$4.98K
4
Two Sigma Investments
Two Sigma Investments
New York
+$4.74K
5
JAIC
Josh Arnold Investment Consultant
Minnesota
+$4.38K

Top Sellers

Rank Fund Capital Flow
1
JFG
Jefferies Financial Group
New York
-$8.73K
2
WAM
Wolverine Asset Management
Illinois
-$1.86K
3
Citadel Advisors
Citadel Advisors
Florida
-$1.68K
4
UBS Group
UBS Group
Switzerland
-$88
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
1
LMR Partners
United Kingdom
$325K +$4.98K +31,500 +2%
DM
2
Deerfield Management
New York
$250K – – –
JAIC
3
Josh Arnold Investment Consultant
Minnesota
$62.9K +$4.38K +27,704 +7%
Walleye Capital
4
Walleye Capital
New York
$51.2K +$9.51K +60,208 +18%
DKCM
5
Davidson Kempner Capital Management
New York
$39.8K – – –
CAC
6
Cowen and Company
New York
$24.3K +$63 +400 +0.3%
WAM
7
Wolverine Asset Management
Illinois
$13.2K -$1.86K -11,789 -15%
Man Group
8
Man Group
United Kingdom
$11.5K +$14K +88,824 New
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
9
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$11.4K – – –
TCM
10
Tenor Capital Management
New York
$5K – – –
Two Sigma Investments
11
Two Sigma Investments
New York
$3.75K +$4.74K +30,000 New
AGM
12
Alpine Global Management
New York
$3.25K – – –
Citadel Advisors
13
Citadel Advisors
Florida
$2.89K -$1.68K -10,624 -32%
FL
14
FreeGulliver LLC
Louisiana
$2.31K +$2.92K +18,500 New
CS
15
Clear Street
New York
$319 +$79 +500 +46%
Bank of America
16
Bank of America
North Carolina
$25 +$32 +200 New
JFG
17
Jefferies Financial Group
New York
– -$8.73K -95,000 Closed
UBS Group
18
UBS Group
Switzerland
– -$88 -1,034 Closed

STLNW Hedge Fund Activity: Q4 2023 in Review

16 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Starling Oncology, Inc. Warrant (STLNW) for Q4 2023, worth a combined $807K — up 98% from $407K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new STLNW positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Man Group, opening a new position worth an estimated $14K. The largest seller was Jefferies Financial Group, exiting entirely with an estimated $8.73K sold.

  • 16 institutional investors held Starling Oncology, Inc. Warrant (STLNW) as of Q4 2023, up from 14 in Q3 2023.
  • Funds reported $807K of Starling Oncology, Inc. Warrant stock for Q4 2023, up 98% quarter-over-quarter.
  • 4 funds opened new Starling Oncology, Inc. Warrant positions in Q4 2023 and 2 closed out, a net change of +2 holders.
  • The largest Starling Oncology, Inc. Warrant buyer in Q4 2023 was Man Group, an estimated $14K added.
  • The largest Starling Oncology, Inc. Warrant seller in Q4 2023 was Jefferies Financial Group, an estimated $8.73K sold.

Based on aggregated 13F filings for Q4 2023.